345 related articles for article (PubMed ID: 8780385)
21. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
[TBL] [Abstract][Full Text] [Related]
22. Cell-binding domain of endothelial cell thrombospondin: localization to the 70-kDa core fragment and determination of binding characteristics.
Dardik R; Lahav J
Biochemistry; 1991 Sep; 30(38):9378-86. PubMed ID: 1716458
[TBL] [Abstract][Full Text] [Related]
23. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
24. The antiangiogenic effect of thrombospondin-2 is mediated by CD36 and modulated by histidine-rich glycoprotein.
Simantov R; Febbraio M; Silverstein RL
Matrix Biol; 2005 Feb; 24(1):27-34. PubMed ID: 15748999
[TBL] [Abstract][Full Text] [Related]
25. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin.
San Antonio JD; Slover J; Lawler J; Karnovsky MJ; Lander AD
Biochemistry; 1993 May; 32(18):4746-55. PubMed ID: 8490019
[TBL] [Abstract][Full Text] [Related]
26. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1.
Adams JC; Lawler J
Mol Biol Cell; 1994 Apr; 5(4):423-37. PubMed ID: 7519904
[TBL] [Abstract][Full Text] [Related]
27. Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells.
Schön P; Vischer P; Völker W; Schmidt A; Faber V
Eur J Cell Biol; 1992 Dec; 59(2):329-39. PubMed ID: 1493798
[TBL] [Abstract][Full Text] [Related]
28. Regulation of neovascularization by human neutrophil peptides (alpha-defensins): a link between inflammation and angiogenesis.
Chavakis T; Cines DB; Rhee JS; Liang OD; Schubert U; Hammes HP; Higazi AA; Nawroth PP; Preissner KT; Bdeir K
FASEB J; 2004 Aug; 18(11):1306-8. PubMed ID: 15208269
[TBL] [Abstract][Full Text] [Related]
29. Human microvascular endothelial cells adhere to thrombospondin-1 via an RGD/CSVTCG domain independent mechanism.
Chen ZS; Pohl J; Lawley TJ; Swerlick RA
J Invest Dermatol; 1996 Feb; 106(2):215-20. PubMed ID: 8601718
[TBL] [Abstract][Full Text] [Related]
30. The effect of thrombospondin on invasion of fibrin gels by human A549 lung carcinoma.
Hosokawa T; Muraishi A; Rothman VL; Papale M; Tuszynski GP
Oncol Res; 1993; 5(4-5):183-9. PubMed ID: 8305744
[TBL] [Abstract][Full Text] [Related]
31. The effect of heparin on fibronectin and thrombospondin synthesis and mRNA levels in cultured human endothelial cells.
Lyons-Giordano B; Brinker JM; Kefalides NA
Exp Cell Res; 1990 Jan; 186(1):39-46. PubMed ID: 1688801
[TBL] [Abstract][Full Text] [Related]
32. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity.
Murphy-Ullrich JE; Gurusiddappa S; Frazier WA; Höök M
J Biol Chem; 1993 Dec; 268(35):26784-9. PubMed ID: 8253815
[TBL] [Abstract][Full Text] [Related]
33. The effect of thrombospondin on oral squamous carcinoma cell invasion of collagen.
Wang TN; Qian XH; Granick MS; Solomon MP; Rothman VL; Tuszynski GP
Am J Surg; 1995 Nov; 170(5):502-5. PubMed ID: 7485743
[TBL] [Abstract][Full Text] [Related]
34. Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1.
Chen H; Sottile J; Strickland DK; Mosher DF
Biochem J; 1996 Sep; 318 ( Pt 3)(Pt 3):959-63. PubMed ID: 8836144
[TBL] [Abstract][Full Text] [Related]
35. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1.
Merle B; Malaval L; Lawler J; Delmas P; Clezardin P
J Cell Biochem; 1997 Oct; 67(1):75-83. PubMed ID: 9328841
[TBL] [Abstract][Full Text] [Related]
36. Selective inhibition of platelet macroaggregate formation by a recombinant heparin-binding domain of human thrombospondin.
Legrand C; Morandi V; Mendelovitz S; Shaked H; Hartman JR; Panet A
Arterioscler Thromb; 1994 Nov; 14(11):1784-91. PubMed ID: 7947604
[TBL] [Abstract][Full Text] [Related]
37. Role of thrombospondin in mesangial cell growth: possible existence of an autocrine feedback growth circuit.
Marinides GN; Suchard SJ; Mookerjee BK
Kidney Int; 1994 Aug; 46(2):350-7. PubMed ID: 7967346
[TBL] [Abstract][Full Text] [Related]
38. Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation.
Murphy-Ullrich JE; Mosher DF
J Cell Biol; 1987 Oct; 105(4):1603-11. PubMed ID: 2444599
[TBL] [Abstract][Full Text] [Related]
39. Neutrophil thrombospondin receptors are linked to GTP-binding proteins.
Suchard SJ; Mansfield PJ
J Cell Physiol; 1996 Jul; 168(1):217-27. PubMed ID: 8647918
[TBL] [Abstract][Full Text] [Related]
40. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor.
Yabkowitz R; Dixit VM
Cancer Res; 1991 Jul; 51(14):3648-56. PubMed ID: 1712244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
